Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-08-28 to 2024-09-19
Current total value of award: $3424.46
Description: 4565683694!XOLAIR 300 MG/2 ML SYRINGE 2ML